Indefinite Delivery Contract SPE2DB25D9303

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The single-award IDC, valued up to $499,999,999, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to fulfill the recurring medical supply needs of military health facilities worldwide under the SPE2DB program.

The IDC covers a vast array of pharmaceutical items, from common medications like antibiotics and cardiovascular drugs to specialized products such as oncology drugs, biologics, and medical consumables. This contract allows DMS Pharmaceutical Group to serve as a crucial supplier in the federal pharmaceutical supply chain, providing both routine and critical medications to support the diverse medical requirements of military personnel and their dependents across various Department of Defense healthcare facilities. The contract has an ultimate completion date of November 30, 2026.